SeRenade Parent-Child Music Class Program

February 5, 2022 updated by: Miriam Lense, Vanderbilt University Medical Center

SeRenade Parent-Child Music Class Program for Families of Children With and Without ASD

This pilot study examines the impact of the SeRenade Parent-Child Music Class Program, which emphasizes parent training, peer inclusion, and musical play combined with established behavioral techniques, on the development of child social engagement, positive behavior, and parental well-being.

Study Overview

Detailed Description

This pilot study evaluates the impact of the SeRenade Parent-Child Music Class Program on families of children with and without autism spectrum disorders (ASD). This study examines the impact of this program on social development in children with ASD, parental stress and efficacy, and parent-child relationships. A primary goal of this study is to examine multiple levels of analysis including families' experience within and outside of the music class program.

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Tennessee
      • Nashville, Tennessee, United States, 37232
        • Vanderbilt University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 6 years (CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • children diagnosed with ASD or children without ASD

Exclusion Criteria:

  • currently enrolled in music therapy or parent-child music classes (for children with ASD); significant behavior problems (e.g., aggression toward other children); significant hearing or visual impairments

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: SeRenade Program
Parent-Child Music Class Program (parent training, peer inclusion, musical play)
Parent-Child Music Class involving parent training, peer inclusion, and musical play
EXPERIMENTAL: Delayed/Waitlist Program
Participants do not participate in the program for a time period
Participants receive intervention after delay

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Motor Imitation Scale
Time Frame: Change from pre to post program (baseline and 12-weeks)
Standardized elicited imitation assessment; scores range 0-32; greater scores indicate greater imitation skills
Change from pre to post program (baseline and 12-weeks)
Actions & Gestures
Time Frame: Change from pre to post program (baseline and 12-weeks)
Standardized parent report questionnaire of child's gestures/actions/pretend play
Change from pre to post program (baseline and 12-weeks)
Parenting Stress Index, 4th edition Short Form
Time Frame: Change from pre to post program (baseline and 12-weeks)
Standardized parent report questionnaire
Change from pre to post program (baseline and 12-weeks)
Parenting Efficacy/Quality
Time Frame: Change from pre to post program (baseline and 12-weeks)
Parent report questionnaire; higher scores indicate greater efficacy, range 10-40
Change from pre to post program (baseline and 12-weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Parent-Child Interaction
Time Frame: Change from pre to post program (baseline and 12-weeks)
parent-child play/music session
Change from pre to post program (baseline and 12-weeks)
social visual attention eye-tracking paradigm
Time Frame: Change from pre to post program (baseline and 12-weeks)
Change from pre to post program (baseline and 12-weeks)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
parent mood/connection
Time Frame: change from before/after the class session at class 1 (week 1) to 12 (week 12) (a session of classes is 12-weeks on average)
parent ratings
change from before/after the class session at class 1 (week 1) to 12 (week 12) (a session of classes is 12-weeks on average)
Program acceptability
Time Frame: post program (12 weeks)
parent program evaluation survey
post program (12 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 15, 2018

Primary Completion (ACTUAL)

December 23, 2019

Study Completion (ACTUAL)

March 20, 2020

Study Registration Dates

First Submitted

May 21, 2018

First Submitted That Met QC Criteria

June 15, 2018

First Posted (ACTUAL)

June 18, 2018

Study Record Updates

Last Update Posted (ACTUAL)

February 8, 2022

Last Update Submitted That Met QC Criteria

February 5, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Deidentified data and codebooks will be available to researchers upon request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe